Evidence map›Paper›PMID 40438230›Full record

ArticleFrontiers in cardiovascular medicine2025

Case Report: Moderate-to-severe paravalvular leak regurgitation after recurrent prosthetic valve endocarditis in a patient with a double-chambered right ventricle associated with a restricted membranous ventricular septal defect.

Cosimo Sacra, Antonio Totaro, Giuseppe Triggiani, Andrea Romano, Pasquale Astore, Chiara Galluccio, Eustaquio Maria Onorato

Abstract readCase Reports
In one paragraph

Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Cosimo SacraInterventional Cardiology Unit, Responsible Research Hospital, Campobasso, Italy.
Antonio TotaroInterventional Cardiology Unit, Responsible Research Hospital, Campobasso, Italy.
Giuseppe TriggianiInterventional Cardiology Unit, Responsible Research Hospital, Campobasso, Italy.
Andrea RomanoInterventional Cardiology Unit, Responsible Research Hospital, Campobasso, Italy.
Pasquale AstoreInterventional Cardiology Unit, Responsible Research Hospital, Campobasso, Italy.
Chiara GalluccioInterventional Cardiology Unit, Responsible Research Hospital, Campobasso, Italy.
Eustaquio Maria OnoratoUniversity Cardiology Department, IRCCS Galeazzi-Sant'Ambrogio Hospital, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Managing aortic paravalvular leak (PVL) regurgitation following multiple surgical aortic valve replacements (SAVRs) due to recurrent infective endocarditis (IE) presents significant clinical challenges. Case summary: A 46-year-old woman with a history of severe aortic regurgitation and an asymptomatic membranous ventricular septal defect underwent SAVR with a bioprosthetic aortic valve (Perimount 23 mm) in 2005. Concomitantly, a double-chambered right ventricle was diagnosed. Ten years later, due to recurrent IE, another bioprosthetic valve replaced the previous valve (Magna Ease #25). In 2018, she developed sepsis from Discussion: This case highlights the feasibility of transcatheter PVL closure as a less invasive alternative for patients with multiple prior SAVRs and high surgical risk. Advanced imaging techniques were crucial in procedural success, ensuring precise device placement. A multidisciplinary heart team approach is essential for optimizing outcomes in complex valve pathology. Long-term follow-up is necessary to monitor the durability of the closure and potential complications.

Indexed as

double-chambered right ventricleinfective endocarditismembranous ventricular septal defectparavalvular leak closureparavalvular leak regurgitationsurgical aortic valve replacement

Identifiers

PMID40438230
PMCPMC12116576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.